Individuals with potential exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
do not necessarily develop PCR or antibody positivity, suggesting that some …

Correlates of protection for COVID-19 vaccines are urgently needed to license additional
vaccines. We measured immune responses to four COVID-19 vaccines of proven efficacy using …

Patients with hematological malignancies are at increased risk of severe COVID-19 outcomes
due to compromised immune responses, but the insights of these studies have been …

Although children have been largely spared from coronavirus disease 2019 (COVID-19), the
emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of …

T cells can contribute to clearance of respiratory viruses that cause acute-resolving infections
such as SARS-CoV-2, helping to provide long-lived protection against disease. Recent …

Individuals with lymphoid malignancies are at risk of developing severe COVID-19 and are
less likely to develop protective immune responses to SARS-CoV-2 vaccination than the …

Artificial intelligence (AI) has been gaining significant attention in various fields to reduce
costs, increase revenue, and improve customer satisfaction. AI can be particularly beneficial in …

Big Data and Artificial Intelligence (BD&AI) have become so pervasive, and the opportunities
they present so transformative, that they are viewed as essential for competitive growth. …

Human mannose-binding lectin (MBL) is a serum protein of the innate immune system that
circulates as a complex with a group of so-called MBL-associated serine proteases (MASP-1, …

Background The emergence of SARS-CoV-2 has led to the development of serological
assays that could aid in an understanding of the burden of COVID-19 disease. Many available …